Raleigh, NC, United States of America

Michelle Palacios

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Altavant Sciences Gmbh. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michelle Palacios: Innovator in Pulmonary Arterial Hypertension Treatment

Introduction

Michelle Palacios is a notable inventor based in Raleigh, NC (US). She has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension. Her innovative approach has led to the development of a unique dosage regimen that aims to improve patient outcomes.

Latest Patents

Michelle holds 1 patent for her invention titled "Dosage regime and method for treating pulmonary arterial hypertension." This patent outlines a daily dosage regimen that includes two discrete dosage forms, each containing an amount of about 600 mg to about 800 mg of a specific compound. The invention also describes methods for reducing serotonin biosynthesis and achieving significant reductions in urinary 5-HIAA levels.

Career Highlights

Michelle Palacios is associated with Altavant Sciences GmbH, where she continues to work on innovative solutions for treating pulmonary conditions. Her dedication to research and development has positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Eric J Gaukel and Magdalena Alonso-Galicia, who contribute to the collaborative efforts at Altavant Sciences GmbH.

Conclusion

Michelle Palacios exemplifies the spirit of innovation in the medical field, particularly through her work on pulmonary arterial hypertension treatments. Her contributions are paving the way for improved therapeutic options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…